Dasatinib 50 Mg About
Experience unprecedented savings and magnificent efficacy with DasaMyl (Mylan) Dasatinib 50 mg tablets, crafted with the finest standards for treating chronic myeloid leukemia in adults. This anti-cancer medication, supplied in a secure 60-tablet box, brings you competitive pricing without compromising on quality. Each film-coated, white tablet delivers 50 mg of Dasatinib, ideal for oncology applications. As a prescription medicine, it ensures targeted leukemia treatment under medical guidance. Take advantage of this extraordinary offer and benefit from the reliability and trustworthiness of a leading Indian exporter, manufacturer, and supplier.
Enhancing Oncology Treatment with a Robust Dosage Solution
Dasatinib 50 mg tablets are engineered with precision as film-coated tablets for adult oncology patients. Their robust composition ensures consistency in physical form and dosage. With Dasatinib as the primary ingredient, these tablets function as a potent anti-cancer therapy for leukemia. They exhibit outstanding stability and are packaged to preserve efficacy. Fully compliant with pharmaceutical standards, DasaMyl's application media is tailored for oral administration, simplifying the patient regimen during prolonged treatment cycles.
Sample Policy and Reliable International Logistics
Our policy ensures transparent sampling for Dasatinib 50 mg, enabling clients to evaluate the product before initiating large-scale orders. Delivery times are optimized for efficiency, with secure shipping and prompt freight handling post purchase order confirmation. Exports are processed via trusted Indian FOB ports, guaranteeing safe and timely reception worldwide. Each shipment is meticulously packaged to maintain pharmaceutical integrity, ensuring clients receive their medicines in optimal condition.
FAQ's of Dasatinib 50 Mg:
Q: How should Dasatinib 50 mg tablets be administered?
A: Dasatinib 50 mg tablets must be taken orally, exactly as directed by your physician. It is important to follow the prescribed dosage and regimen to ensure optimal treatment outcomes.
Q: What benefits does Dasatinib 50 mg offer in leukemia treatment?
A: Dasatinib 50 mg is renowned for its efficacy in managing chronic myeloid leukemia in adults. It works as a targeted anti-cancer therapy, aiding in effective disease control under supervised care.
Q: When should patients start or stop using Dasatinib 50 mg?
A: Patients should begin or end the medication only upon the oncologist's recommendation. The duration of treatment is individualized based on medical assessment and response to therapy.
Q: Where is DasaMyl (Mylan) Dasatinib 50 mg manufactured and exported from?
A: DasaMyl (Mylan) Dasatinib 50 mg is manufactured and exported from pharmaceutical facilities located in India, adhering to stringent international quality guidelines.
Q: What is the storage protocol for Dasatinib 50 mg tablets?
A: To maintain potency, store Dasatinib 50 mg tablets below 30C in a dry place, always checking the expiry date on the packaging before use.
Q: How can international clients receive samples or place purchase orders?
A: Clients can request samples and place purchase orders through our streamlined process. Secure freight shipping is arranged upon order confirmation, ensuring prompt and reliable delivery.